| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:519349928:2061 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:519349928:2061?format=raw |
LEADER: 02061cam a2200433 i 4500
001 3961881
005 20221027010738.0
008 911218s1981 ne a b 101 0 eng
010 $a 81001155
020 $a9021994720 (Excerpta Medica)
020 $a0444901906 (Elsevier North-Holland)
035 $a(OCoLC)7283264
035 $a(OCoLC)ocm07283264
035 $a(CStRLIN)NYCM91-B6970
035 $9AFV9368HS
035 $a(NNC)3961881
035 $a3961881
040 $dNNC-M
050 10 $aRM666.V49$bI57 1980
060 0 $aW3 EX89 no.543 1980$aQV 150 I5908c 1980
082 0 $a616.1/061$219
111 2 $aInternational Symposium on Calcium Antagonism in Cardiovascular Therapy$d(1980 :$cFlorence, Italy)$0http://id.loc.gov/authorities/names/n81008733
245 10 $aCalcium antagonism in cardiovascular therapy :$bexperience with verapamil : proceedings of the International Symposium on Calcium Antagonism in Cardiovascular Therapy, Florence, 2-4 October, 1980 /$ceditors, Alberto Zanchetti, Dennis Krikler.
260 $aAmsterdam ;$aPrinceton :$bExcerpta Medica ;$aNew York :$bDistributors for the USA and Canada, Elsevier North-Holland,$c1981.
300 $aix, 429 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aIncludes indexes.
504 $aIncludes bibliographical references.
650 0 $aVerapamil$xPhysiological effect$vCongresses.
650 0 $aCalcium$xAntagonists$vCongresses.
650 0 $aCardiovascular system$xDiseases$xChemotherapy$vCongresses.
650 2 $aCalcium$xantagonists & inhibitors.
650 2 $aCardiovascular Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D002318Q000188
650 2 $aVerapamil$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014700Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aZanchetti, Alberto.$0http://id.loc.gov/authorities/names/n81013497
700 1 $aKrikler, Dennis M.$0http://id.loc.gov/authorities/names/n81009555
852 00 $boff,hsl$hRM666.V49$iI57 1980